Abstract
Morphine, as the prototype of a central analgesic drug, has characteristic adverse effects that are relevant to the treatment of patients. Important among these effects are the following:
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Further Reading
Aceto MD (1990) Assessment of physical dependence techniques for the evaluation of abused drugs. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 67–79
Acquas E, Di Chiara G (1994) D1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion. Behav Pharmacol 5:555–560
Acquas E, Carboni E, Garau L, Di Chiara G (1990) Blockade of acquisition of drug-conditioned place aversion by 5-HT3antagonists. Psychopharmacology 100:459–463
Amalric M, Cline EJ, Martinez JL Jr, Bloom FE, Koob GF (1987) Rewarding properties of β-endorphin as measured by conditioned place preference. Psychopharmacology 91:14–19
Bals-Kubik R, Herz A, Shippenberg TS (1988) β-endorphin-(1–27) is a naturally occurring antagonist of the reinforcing effects of opioids. Naunyn-Schmiedeberg’s Arch Pharmacol 338:392–396
Bals-Kubik R, Shippenberg TS, Herz A (1990) Involvement of central μ and δ opioid receptors in mediating the reinforcing effects of β-endorphin in the rat. Eur J Pharmacol 175:63–69
Balster RL, Prescott WR (1990) Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci Behav Rev 16:55–62
Bechara A, Van der Kooy D (1987) Kappa receptors mediate the peripheral aversive effects of opiates. Pharmacol Biochem Behav 28:227–233
Bechtholt AJ, Gremel CM, Cunningham CL (2004) Handling blocks expression of conditioned place aversion but not conditioned place preference by ethanol in mice. Pharmacol Biochem Behav 79:739–744
Bertalmio AJ, Woods JH (1987) Differentiation between μ and κ receptor mediated effects in opioid drug discrimination: apparent pA2analysis. J Pharmacol Exp Ther 243:591–598
Bertalmio AJ, Herling S, Hampton RY, Winger G, Woods JH (1982) A procedure for rapid evaluation of the discriminative stimulus effects of drugs. J Pharmacol Methods 7:289–299
Bormann NM, Cunningham CL (1998) Ethanol-induced conditioned place aversion in rats: effects of interstimulus interval. Pharmacol Biochem Behav 59:427–432
Bozarth MA (1987) Intracranial self-administration procedures for the assessment of drug reinforcement. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 178–187
Brady JV, Griffiths RR, Hienz RD, Ator NA, Lukas SE, Lamb RJ (1987) Assessing drugs for abuse liability and dependence potential in laboratory primates. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 45–85
Brandt MR, France CP (1998) Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal. J Pharmacol Exp Ther 287:1029–1037
Broadbent J, Muccino KJ, Cunningham CL (2002) Ethanol-induced conditioned taste aversion in 15 inbred mouse strains. Behav Neurosci 116:138–148
Brockwell NT, Beninger RJ (1996) The differential role of A1 and A2 adenosine subtypes in locomotor activity and place conditioning in rats. Behav Pharmacol 7:373–383
Brockwell NT, Eikelboom R, Beninger RJ (1991) Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion. Pharmacol Biochem Behav 38:513–517
Brockwell NT, Ferguson DS, Beninger RJ (1996) A computerized system for the simultaneous monitoring of place conditioning and locomotor activity in rats. J Neurosci Methods 64:227–232
Buckett WR (1964) A new test for morphine-like physical dependence (addiction liability) in rats. Psychopharmacologia 6:410–416
Butelman ER, France CP, Woods JH (1993) Apparent pA2analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys. J Pharmacol Exp Ther 264:145–151
Calcagnetti DJ, Quatrella LA, Schechter MD (1996) Olfactory bulbectomy disrupts the expression of cocaine-induced conditioned place preference. Physiol Behav 59:597–604
Carboni E, Acquas E, Leone P, di Chiara G (1989) 5-HT3receptor antagonists block morphine- and nicotine- but not amphetamine-induced award. Psychopharmacology 97:175–178
Chan PC (2000) NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344/N rats and B6C3F1 mice. Toxic Rep Ser (56):1–G14
Chaperon F, Thiébot MH (1996) Effects of dopaminergic D3-receptor-preferring ligands on the acquisition of place conditioning in rats. Behav Pharmacol 7:105–109
Collier HOJ, Cuthbert NJ, Francis DL (1979) Effects of time and drug concentration on the induction of responsiveness to naloxone in guinea pig ileum exposed to normorphine in vitro. Br J Pharmacol 69:332P–333P
Colpaert FC (1987) Drug discrimination: methods of manipulation, measurement, and analysis. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 341–372
Colpaert FC, Janssen PAJ (1984) Agonist and antagonist effects of prototype opiate drugs in rats discrimination fentanyl from saline: characteristics of partial generalization. J Pharmacol Exp Ther 220:193–199
Contarino A, Zanotti A, Drago F, Natolino F, Lipartiti M, Giusti P (1997) Conditioned place preference: no tolerance to the rewarding properties of morphine. Naunyn-Schmiedeberg’s Arch Pharmacol 355:589–594
Cowan A, Zhu XZ, Mosberg HI, Omnaas JR, Porreca F (1988) Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther 246:950–955
Cruz SL, Salazar LA, Villarreal JE (1991) A methodological basis for improving the reliability of measurements of opiate abstinence responses in the guinea pig ileummade dependent in vitro. J Pharmacol Methods 25:329–342
Davies AM, Parker LA (1993) Fenfluramine-induced place aversion in a three-choice apparatus. Pharmacol Biochem Behav 44:595–600
Del Poso E, Barrios M, Baeyens JM (1996) The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference in mice. Psychopharmacology 125:209–213
Deneau GA (1964) Pharmacological techniques for evaluating addiction liability of drugs. In: Nodine JH, Siegler PE (eds) Animal and clinical pharmacologic techniques in drug evaluation. Year Book Medical Publication, Chicago, pp 406–410
Deneau GA, Seevers MH (1964) Drug dependence. In: Laurence DR, Bacharach AL (eds) Evaluation of drug activities: pharmacometrics. Academic, London/New York, pp 167–179
Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16:30–48
Dykstra LA, Gmerek DE, Winger G, Woods JH (1987) Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther 242:413–420
Dykstra LA, Bertalmio AJ, Woods JH (1988) Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2analysis. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli, vol 4, Psychopharmacology series. Springer, Berlin/Heidelberg/New York, pp 107–121
France CP (1995) A sensitive, efficient drug discrimination procedure for studying kappa antagonists in rhesus monkeys. Analgesia 1:421–424
France CP, Woods JH (1993) U-50488, saline, naltrexone discrimination in U-50,488 treated pigeons. Behav Pharmacol 4:509–516
France CP, Medzihradsky F, Woods JH (1994) Comparison of kappa opioids in rhesus monkeys: behavioral effects and binding affinities. J Pharmacol Exp Ther 268:47–58
France CP, Gerak LR, Winger GD, Medzihradsky F, Bagley JR, Brockunier LL, Woods JH (1995) Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys. J Pharmacol Exp Ther 274:17–28
Frisch C, Hasenöhrl RU, Mattern CM, Häcker R, Huston JP (1995) Blockade of lithium chloride-induced conditioned place aversion as a test for antiemetic agents: comparison of metoclopramide with combined extracts of Zingiber officinale and Ginkgo biloba. Pharmacol Biochem Behav 52:321–327
Gabriel KI, Cunningham CL, Finn DA (2004) Allopregnanolone does not influence ethanol-induced conditioned place preference in DBA/2J mice. Psychopharmacology 176:50–56
Gaiardi M, Bartoletti M, Bacchi A, Gubellini C, Babbibi M (1997) Motivational properties of buprenorphine as assessed by place and taste conditioning in rats. Psychopharmacology 130:104–108
Garcia J, Kimmeldorf DJ, Koelling RA (1955) Conditioned taste aversion to saccharin resulting from exposure to gamma irradiation. Science 122:157–158
Gatley SJ, Meehan SM, Chen R, Pan D-F, Schechter MD, Dewey SL (1996) Place preference and microdialysis studies with two derivatives of methylphenidate. Life Sci 58:PL345–PL352
Geller EB, Adler MW (1990) Drugs of abuse and body temperature. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 101–109
Gellert VF, Holtzman SG (1978) Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphing drinking solutions. J Pharmacol Exp Ther 205:536–546
Gerak LR, Butelman ER, Woods JH, France CP (1994) Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 271:993–999
Glassman JM (1971) Agents with analgesic activity and dependence liability. In: Turner RA, Hebborn P (eds) Screening methods in pharmacology, vol II. Academic, London/New York, pp 227–248
Gmerek DE, Dykstra LA, Woods JH (1987) Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration. J Pharmacol Exp Ther 242:428–436
Gutierrez T, Crystal JD, Zvonok AM, Makriyannis A, Hohmann AG (2011) Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain. Pain 152(9):1976–1987
Hein DW, Young AM, Herling S, Woods JH (1981) Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey. J Pharmacol Exp Ther 218:7–15
Herling S, Woods JH (1981) Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. Life Sci 28:1571–1584
Higgins GA, Joharchi N, Sellers EM (1993) Behavioral effects of the 5-hydroxytryptamine3receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. J Pharmacol Exp Ther 264:1440–1449
Hoffman DC (1989) The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res Bull 23(4–5):373–387
Hoffman DC, Donovan H (1995) Effects of typical, atypical, and novel antipsychotic drugs on amphetamine-induced place conditioning in rats. Drug Dev Res 36:193–198
Hoffmeister F (1979) Preclinical evaluation of reinforcing and aversive properties of analgesics. In: Beers RF, Bassett EG (eds) Mechanics of pain and analgesic compounds. Raven, New York, pp 447–466
Hoffmeister F (1988) A comparison of the stimulus effects of codeine in rhesus monkeys under the contingencies of a two lever discrimination task and a cross self-administration paradigm: tests of generalization to pentazocine, buprenorphine, tilidine, and different doses of codeine. Psychopharmacology 94:315–320
Holtzman SG (1983) Discriminative stimulus properties of opioid agonists and antagonists. In: Cooper SJ (ed) Theory in psychopharmacology, vol 2. Academic, London, p 145
Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 193–210
Holtzman SB, Villarreal JE (1969) Morphine dependence and body temperature in rhesus monkeys. J Pharmacol Exp Ther 166:124–133
Howell LL, Bergman J, Morse WH (1988) Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys. J Pharmacol Exp Ther 245:364–372
Iwamoto ET (1988) Dynorphin A [1–17] induces ‘reward’ in rats in the place conditioning paradigm. Life Sci 43:503–508
Jarbe TU, Swedberg MD (1998) Discriminative stimulus functions of CNS sedative drugs assessed by drug versus drug discrimination procedures in gerbils. Psychopharmacology 135:201–212
Johnson-Davis KL, Hanson GR, Keefe KA (2003) Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats. Neurotox Res 5(4):273–281
Kalant H, Khanna JM (1990) Methods for the study of tolerance. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 43–66
Katz JL (1986) Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys. Psychopharmacology 88:392–397
Kest B, Palmese CA, Hopkins E, Adler M, Juni A, Mogil JS (2002) Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115:463–469
Khanna JM, Mayer JM, Lê AD, Kalant H (1984) Differential response to ethanol, pentobarbital and morphine in mice specially bred for ethanol sensitivity. Alcohol 1:447–451
Khroyan TV, Baker DA, Neisewander JL (1995) Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology 122:351–357
Khroyan TV, Fuchs RA, Baker DA, Neisewander JL (1997) Effects of D3-preferring agonists 7-OH-PIPAT and PD-128,907 on motor behaviors and place conditioning. Behav Pharmacol 8:65–74
Kilic FS, Dogan AE, Baydemir C, Erol K (2011) The acute effects of mirtazapine on pain related behavior in healthy animals. Neurosciences (Riyadh) 16(3):217–223
Kitaichi K, Noda Y, Hasegawa T, Furukawa H, Nabeshima T (1996) Acute phencyclidine induces aversion, but repeated phencyclidine induces preference in the place conditioning test in rats. Eur J Pharmacol 318:7–9
Kornetsky C, Bain B (1990) Brain-stimulation reward: a model for drug-induced euphoria. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 67–79
Kosten TA (1994) Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal. Eur J Pharmacol 254:59–63
Lal H, Sherman GT (1980) Interceptive discriminative stimuli in the development of CNS drugs and a case of an animal model of anxiety. Annu Rep Med Chem 15:51–58
Langerman L, Zakowski MI, Piskoun B, Grant GJ (1995) Hot plate versus tail flick: evaluation of acute tolerance to continuous morphine infusion in the rat model. J Pharmacol Toxicol Methods 34:23–27
Lepore M, Vorel SR, Lowinson J, Gardner EL (1995) Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparison with cocaine, morphine, and food award. Life Sci 56:2073–2080
Liguori A, Morse WH, Bergman J (1996) Respiratory effects of opioid full and partial agonists in rhesus monkeys. J Pharmacol Exp Ther 277:462–472
Ling GSF, Spiegel K, Nishimura S, Pasternack GW (1983) Dissociation of morphine’s analgesic and respiratory depressant actions. Eur J Pharmacol 86:478–488
Ling GSF, Spiegel K, Lockhart SH, Pasternack GW (1985) Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J Pharmacol Exp Ther 232:149–155
Littmann K, Heredia JM, Hoffmeister F (1979) Eine neue methode zur enteralen verabreichung von psychotrop wirksamen substanzen beim rhesusaffen. Arzneim Forsch/Drug Res 29:1888–1890
Locke KW, Gorney B, Cornfeldt M, Fielding S (1991) Comparison of the stimulus effects of ethylketocyclazocine in Fischer and Sprague-Dawley rats. Drug Dev Res 23:65–73
Mamoon AM, Barnes AM, Ho IK, Hoskins B (1995) Comparative rewarding properties of morphine and butorphanol. Brain Res Bull 38:507–511
Marcus R, Kornetsky C (1974) Negative and positive intracranial thresholds: effects of morphine. Psychopharmacologia 38:1–13
Martellotta MC, Fattore L, Cossu G, Fratta W (1997) Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm. Psychopharmacology 132:1–5
Martin WR, Eades CG, Thompson WO, Thompson JA, Flanary HG (1974) Morphine physical dependence in the dog. J Pharmacol Exp Ther 189:759–771
Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532
Martin-Iverson MT, Reimer AR (1996) Classically conditioned motor effects do not occur with cocaine in an unbiased conditioned place preferences procedure. Behav Pharmacol 7:303–314
Martin-Iverson MT, Reimer AR, Sharma S (1997) Unbiased cocaine conditioned place preferences (CPP) obscures conditioned locomotion, and nimodipine blockade of cocaine CPP is due to conditioned place aversions. Psychopharmacology 130:327–333
McDougal JN, Marques PR, Burks TF (1983) Restraint alters the thermic response to morphine by postural interference. Pharmacol Biochem Behav 18:495–499
Meert TF, Janssen PAJ (1989) Psychopharmacology of ritanserin: comparison with chlordiazepoxide. Drug Dev Res 18:119–144
Meert TF, de Haes P, Janssen PAJ (1989) Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats. Psychopharmacology 97:206–212
Meert TF, de Haes LAJ, Vermote PCM, Janssen PAJ (1990) Pharmacological validation of ritanserin and risperidone in the drug discrimination procedure in the rat. Drug Dev Res 19:353–373
Meisch RA, Carroll ME (1987) Oral drug self-administration: drugs as reinforcers. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 143–160
Mucha RF, Herz A (1985) Motivational properties of kappa and mu-opioid agonists studied with place and taste preference conditioning procedures. Psychopharmacology 82:241–245
Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. Psychopharmacology 82:241–247
Murphy DJ, Joran ME, Grando JC (1995) A non-invasive method for distinguishing central from peripheral nervous system effect of respiratory depressant drugs in conscious rats. Gen Pharmacol 26:569–575
Nelson RB, Elliott HW (1967) A comparison of some central effects of morphine, morphinone and thebaine on rats and mice. J Pharmacol Exp Ther 155:516–520
Olds J (1979) Drives and reinforcements: behavioral studies of hypothalamic functions. Raven, New York
Olds J, Killam KF, Bachy-Rita P (1956) Self-stimulation of the brain used as screening method for tranquilizing drugs. Science 124:265–266
Overton DA (1987) Applications and limitations of the drug discrimination method for the study of drug abuse. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 291–340
Pain L, Oberling P, Sandner G, Di Scala G (1997) Effect of midazolam on propofol-induced positive affective state assessed by place conditioning in rats. Anesthesiology 87:935–943
Papp M, Moryl E, Maccechini ML (1996) Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model. Eur J Pharmacol 317:191–196
Parker LA (1996) LSD produces place preference and flavor avoidance but does not produce flavor aversion in rats. Behav Neurosci 110:503–508
Pasternak GW (1987) Opioid receptors. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 281–288
Paxinos G, Watson C (1982) The rat in stereotaxic coordinates. Academic, Sidney
Perks SM, Clifton PG (1997) Reinforcer revaluation and conditioned place preference. Physiol Behav 61:1–5
Pierce TL, Raper C (1995) The effects of laboratory handling procedures on naloxone-precipitated withdrawal behavior in morphine-dependent rats. J Pharmacol Toxicol Methods 34:149–155
Pierce TL, Hope W, Raper C (1996) The induction and quantitation of methadone dependence in the rat. J Pharmacol Toxicol Methods 36:137–146
Porsolt RD, Lemaire M, Dürmüller N, Roux S (2002) New perspectives in CNS safety pharmacology. Fundam Clin Pharmacol 16(3):197–207
Rahn EJ, Thakur GA, Wood JA, Zvonok AM, Makriyannis A, Hohmann AG (2011) Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects. Pharmacol Biochem Behav 98(4):493–502
Riba P, Ben Y, Smith AP, Furst S, Lee NM (2002) Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors. J Pharmacol Exp Ther 300:265–272
RodrÃguez R, Luján M, Campos AE, Chorné R (1978) Morphine-dependence in the isolated guinea pig ileum and its modification by p-chlorophenylalanine. Life Sci 23:913–920
Saelens JK, Granat FR, Sawyer WK (1971) The mouse jumping test: a simple screening method to estimate the physical dependence capacity of analgesics. Arch Int Pharmacodyn 190:213–218
Sante AB, Nobre MJ, Brandao ML (2000) Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. Behav Pharmacol 11:583–589
Sañudo-Peña CM, Tsou K, Delay ER, Hohman AG, Force M, Walker JM (1997) Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 223:125–128
Schechter MD, Meehan SM (1994) Conditioned place aversion produced by dopamine release inhibition. Eur J Pharmacol 260:133–137
Seevers MH (1963) Opiate addiction in the monkey. I. Methods of study. J Pharmacol Exp Ther 56:147–156
Seevers MH, Deneau GA (1963) Physiological aspects of tolerance and physical dependence. In: Root WS, Hoffman FG (eds) Physiological pharmacology, vol I. Academic, New York/London, p 565
Self DW, Stein L (1992) Receptor subtypes in opioid and stimulation reward. Pharmacol Toxicol 70:87–94
Shannon HE, Holtzman SG (1976) Evaluation of the discriminative effects of morphine in the rat. J Pharmacol Exp Ther 198:64–65
Shannon HE, Holtzman SG (1986) Blockade of the discriminative effects of morphine by naltrexone and naloxone. Psychopharmacologia 50:119–124
Shelton KL, Dukat M, Allan AM (2004) Effects of 5-HT3receptor over-expression on the discriminative stimulus effects of ethanol. Alcohol Clin Exp Res 28:1161–1171
Sherman G, Lal H (1979) Discriminative stimulus properties of pentylenetetrazol and begrimide: some generalization and antagonism tests. Psychopharmacology 64:315–319
Sherman GT, Lal H (1980) Generalization and antagonism studies with convulsants, GABAergic and anticonvulsant drugs in rats trained to discriminate pentylenetetrazol from saline. Neuropharmacology 19:473–479
Sherman GT, Miksic S, Lal H (1979) Lack of tolerance development to benzodiazepines in antagonism of the pentylenetetrazol discriminative stimulus. Pharmacol Biochem Behav 10:795–797
Shippenberg TS, Herz A (1987) Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ- and κ-opioid agonists. Brain Res 436:169–172
Shippenberg TS, Bals-Kubik R, Herz A (1987) Motivational properties of opioids: evidence that an activation of δ-receptors mediate reinforcement processes. Brain Res 436:234–239
Smith FL, Javed RR, Elzey MJ, Dewey WL (2003) The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA. Brain Res 985:78–88
Steinpreis RE, Kramer MA, Mix KS, Piwowarczyk MC (1995) The effects of MK801 on place conditioning. Neurosci Res 22:427–430
Steinpreis RE, Rutell AL, Parrett FA (1996) Methadone produces conditioned place preference in the rat. Pharmacol Biochem Behav 54:339–431
Stolerman IP, Chamberlain S, Bizarro L, Fernandes C, Schalkwyk L (2004) The role of nicotinic receptor alpha 7 subunits in nicotine discrimination. Neuropharmacology 46:363–371
Suebsasana S, Pongnaratorn P, Sattayasai J, Arkaravichien T, Tiamkao S, Aromdee C (2009) Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals. Arch Pharm Res 32(9):1191–1200
Sufka KJ (1994) Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain 58:355–366
Suzuki T, Misawa M (1995) Sertindole antagonizes morphine-, cocaine-, and methamphetamine-induced place preference in the rat. Life Sci 57:1277–1284
Suzuki T, Funada M, Narita M, Misawa M, Nagase H (1991) Pertussis toxin abolishes μ and δ opioid agonist-induced place preference. Eur J Pharmacol 205:85–88
Suzuki T, Funada M, Narita M, Misawa M, Nagase H (1993) Morphine-induced place preference in the CXBK mouse: characteristics of μ opioid receptor subtypes. Brain Res 602:45–52
Ther L, Lindner E, Vogel G (1963) Zur pharmakodynamischen wirkung der optischen isomeren des methadons. Dtsch Apoth Ztg 103:514–520
Tsuji M, Nakagawa Y, Ishibashi Y, Yoshii T, Takashima T, Shimada M, Suzuki T (1996) Activation of ventral tegmental GABAB receptors inhibits morphine-induced place preference in rats. Eur J Pharmacol 313:169–173
Turenne SD, Miles C, Parker LA, Siegel S (1996) Individual differences in reactivity to the rewarding/aversive properties of drugs: assessment by taste and place conditioning. Pharmacol Biochem Behav 53:511–516
Tzschenke M (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613–672
Van der Kooy D (1987) Place conditioning: a simple and effective method for assessing the motivational properties of drugs. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 229–240
van Heest A, Hijzen TH, Slangen JL, Oliver B (1992) Assessment of the stimulus properties of anxiolytic drugs by means of the conditioned taste aversion procedure. Pharmacol Biochem Behav 42:487–495
VonVoigtlander PF, Lewis RA (1983) A withdrawal hyperalgesia test for physical dependence: evaluation of μ and mixed-partial opioid agonists. J Pharmacol Methods 10:277–282
Way EL (1993) Opioid tolerance and physical dependence and their relationship. In: Herz A, Akil H, Simon EJ (eds) Handbook of experimental pharmacology, vol 104, Opioids II. Springer, Berlin/Heidelberg/New York, pp 573–596 (Chap 53)
Way EL, Loh HH, Shen FH (1969) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 167:1–8
Weeks JR, Collins RJ (1987) Screening for drug reinforcement using intravenous self-administration in the rat. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 35–43
Woods JH, France CP, Winger G, Bertamio AJ, Schwarz-Stevens K (1993) Opioid abuse liability assessment in rhesus monkeys. In: Herz A, Akil H, Simon EJ (eds) Handbook of experimental pharmacology, vol 104, Opioids II. Springer, Berlin/Heidelberg/New York, pp 609–632 (Chap 55)
Woolverton WL, Nader MA (1990) Experimental evaluation of the reinforcing effects of drugs. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 67–79
Woolverton WL, Schuster CL (1983) Intragastric self-administration in rhesus monkeys under limited access conditions: Methodological studies. J Pharmacol Methods 10:93–106
Yokel RA (1987) Intravenous self-administration: response rates, the effects of pharmacological challenges, and drug preference. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 1–33
Yoshimura K, Horiuchi M, Konishi M, Yamamoto KI (1993) Physical dependence on morphine induced in dogs via the use of miniosmotic pumps. J Pharmacol Toxicol Methods 30:85–95
Yoshinaga K, Horii T, Hamano H, Eta R, Ozaki T, Orikawa Y, Yoshii K, Kawabata Y, Hori Y, Seto K, Takei M, Kuraishi Y (2010) Pharmacological evaluation of analgesic effects of the cholecystokinin2 receptor antagonist Z-360 in mouse models of formalin- and cancer-induced pain. Biol Pharm Bull 33(2):244–248
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Arendt-Nielsen, L. (2013). Side Effects of Central Analgesic Drugs. In: Vogel, H.G., Maas, J., Hock, F.J., Mayer, D. (eds) Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25240-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-25240-2_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25239-6
Online ISBN: 978-3-642-25240-2
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences